Iomeron (Iomeprol)

Iomeprol contains iodine atoms that absorb X‑ray photons. When injected, the iodine‑rich solution distributes in the vascular and extracellular compartments, raising the attenuation of targeted tissues. This creates a contrast difference on X‑ray‑based images, allowing clearer visualization of vessels, joints, and organ details.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging study, patient weight, renal function, and the required level of contrast. Healthcare professionals calculate the appropriate volume and concentration to achieve optimal image quality while minimizing risk.

The safety of Iomeron in pregnancy and lactation has not been definitively established. It should be used only when clearly necessary, after a careful risk‑benefit assessment by the treating physician. If administered to a nursing mother, the infant may be exposed through breast milk, and clinical judgment is required.

To order Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Iomeron (Iomeprol) is a low‑osmolality, non‑ionic iodinated contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. It provides comparable image enhancement while reducing the incidence of discomfort, warmth sensations, and renal toxicity, making it a preferred choice for many diagnostic imaging procedures.

Iomeron should be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the vial. Keep the product in its original packaging until use, and discard any solution that appears discolored or contains particles.

Iomeron is administered by a qualified healthcare professional via intra‑arterial, intra‑articular, or intravenous injection, depending on the imaging study. The injection is typically performed using a power injector or manual bolus, following aseptic technique and the dosage prescribed by the radiologist or physician.

The most serious risks include severe allergic reactions (anaphylaxis), contrast‑induced nephropathy leading to acute kidney injury, and cardiovascular events such as arrhythmias or hypotension. Patients with known iodine allergy, impaired renal function, or uncontrolled cardiac disease require careful assessment before use.

Iomeron is contraindicated in patients with a documented hypersensitivity to iodinated contrast media, those with uncontrolled severe renal impairment, and individuals who have experienced prior severe anaphylactic reactions to similar agents. Clinicians should also avoid use in patients where the diagnostic benefit does not outweigh the potential risks.